SP-MHCI-0019-1

Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

US$112.00

In stock

Description

About Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY) - Specifications

Amount: 50 µg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in glass vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, Infectious mononucleosis
Standard Delivery Time: 2-5 days

Visit our webpage for more information on Peptide Tools to Study EBV

Are you interested in your other antigen peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

References

References for Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

References:
Read References with Antigen Peptides

Documentation

Documentation for Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

Properties

Properties of Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma
Layout: Freeze-dried in glass vial
Organism: Epstein-Barr Virus (EBV)
Protein Name: BZLF1 Trans-activator protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: Yes

Further Information to Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

Information Values
Sequence: H-EPLPQGQLTAY-OH
Specifications: 11mer peptide as TFA salt
Loading...
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote